chrisvoncsefalvay/vaers-outcomes huggingface dataset:
could not taste breakfast this morning/not being able to taste her food; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (could not taste breakfast this morning/not being able to taste her food) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025821A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, LISINOPRIL, APIXABAN (ELIQUIS), METOPROLOL TARTRATE (LOPRESSOR), SIMVASTATIN, GABAPENTIN, VITAMIN D NOS and FISH OIL for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AGEUSIA (could not taste breakfast this morning/not being able to taste her food). At the time of the report, AGEUSIA (could not taste breakfast this morning/not being able to taste her food) outcome was unknown.            No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow-up information received contains non-significant information- added reporter's address
PAIN AT THE SIGHT OF INJECTION - INJECTION SITE AREA WAS HARD, RED AND BURNING SENSATION FOR THE FIRST 24 HOURS - VISITED EMERGENCY DEPT - PT WAS PRESCRIBED ANTIBIOTICS AT ER. SHE IS FEELING FINE AND COUNTINUING WITH ANTIBIOTICS UNTIL ALL TAKEN
Client called 6/6/11 @ 9:35am with complaint of intense right hip pain which developed one day after receiving Zostavax in right arm. Pain has not resolved, has made it difficult to walk and is unrelieved with OTC medication. Denies any knowledge of contributing factors.
Patient's lips started to swell, itchy throat, back pain and stomachache, no fever, gave benadryl, called 911 after 30mins
Information has been received from a 26 year old female Licensed practical nurse (L.P.N.), concerning herself. The patient had no pertinent medical history and no known drug allergies or reactions. In August 2012 "approximately two weeks ago", the patient was vaccinated with a dose of 0.5 ml VARIVAX (Merck) injection, 0.5 ml single dose (route was not reported) (lot # was not reported). Subsequently in August 2012, "at approximately the same time", between two menstrual cycles, the patient became pregnant with a last menstrual period (LMP) of approximately 27-AUG-2012 and an estimated delivery date (EDD) on 03-JUN-13. The patient did not seek medical attention. At the time of the report, the patient's outcome was unknown. Follow up has been received from licensed practical nurse regarding herself on 05-NOV-2014. This spontaneous report was prospective pregnancy report. On 27-AUG-2013 (reported as 2 weeks ago), the patient was vaccinated with VARIVAX (Merck). The patient became pregnant with LMP of 26-AUG-2012 and EDD of 02-JUN-2013. Initial exposure to VARIVAX (Merck) was at 2 weeks(s). On approximately 11-NOV-12, at 11 weeks gestation, the patient miscarried (medically significant). The pregnancy outcome was spontaneous abortion. Patient became very emotional and did not wanted to discuss any details concerning this report. The outcome of received a dose of VARIVAX and must have conceived a child at approximately the same time was recovered. The outcome of Miscarried at 11 weeks was unknown. Outcome of became emotional was unknown. The causality of Miscarried at 11 weeks with VARIVAX (Merck) and became emotional was unknown. Upon internal review, event spontaneous abortion was considered medically significant. Additional information is not expected.
employee received second dose of covid vaccine 1 week earlier than planned.  1st dose was on 12.28.20, 2nd dose was scheduled for 1.18.21, received dose on 1.11.21.
Jaw was swollen on one side; Arm  itching; A spontaneous report was received from a consumer concerning a 82-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  swollen jaw on one side, and arm itching.   The patient's medical history and concomitant medications was not provided.   On 27-dec-2020 , prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273  intramuscularly  for prophylaxis of COVID-19 infection.  On 10 Jan 2021, 2 weeks after of vaccination, the patient experienced arm itching, that resolved. On 18 Jan 2021, the patients jaw became swollen on one side. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, swollen jaw on one side and arm itching, was considered recovered/ resolved on 20 Jan 2021.; Reporter's Comments: This case concerns an 82-year-old female who experienced nonserious unexpected events of pruritus and face swelling.  Events onset occurred 15 days after the first dose of mRNA-1273. Treatment not reported. Event outcome reported as resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
covid vaccine breakthrough   dose 1 Moderna 5/7/21 006C21A dose 2 Moderna 6/2/21 011D21A
C/O thick tongue, hard to swallow anxious. No SOB, wheezing, no erythema at injection site
Four of my colleagues (including myself) have contracting COVID within a week despite all having been vaccinated; Four of my colleagues (including myself) have contracting COVID within a week despite all having been vaccinated; This is a spontaneous report from a contactable consumer via Pfizer sponsored program via contactable consumer reported for an unknown patient (colleague #1 of 3).   A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 25Jun2021, four of my colleagues (including myself) have contracting COVID within a week despite all having been vaccinated. Exposure could not have occurred before Monday 21Jun2021 and symptom onset (all positive tested individuals were symptomatic) was by 25Jun2021. We were all researchers and recognized the impossibility of this not being a variant. Reporter was totally willing to participate in any studies that might help understand variants and the efficacy of the vaccine on them. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 25Jun2021.The clinical outcome of the events was reported as unknown.  Information about batch/Lot number has been requested.
Large red, swollen area at site of injection  Nausea, diarrhea, stomach cramping
After about 1 week started getting mouth numbing and burning inside of lips, cheeks and gums. Right shoulder of injection site is also still sore and hurts to move arm. Reported issue to primary care. Reaction is still persistent but less severe.
Child had DTaP given on (L) deltoid on 08/21/12. Relative returned to clinic 08/23/12 with child stating childs arm was red, itching, swollen. Deltoid area was warm, red, and swollen in area shot given. Radio medicine/doc phoned. Child was given BENADRYL liquid to take Q6h. Informed to ice area as need, given TYLENOL Q6h as needed. Child was running around active.
Swollen sub/mandibular lymph nodes, left side of face. Noticeable swelling in front of left ear.
Narrative:  Patient died on 10/6/2022 of unknown cause, unknown circumstances, unknown time, unknown place. This did not happen at hospital. Last note in medical chart is dated 2/2/2022. Patient had received a covid vaccine EUA (J&J) on 7/9/2021. Likely covid vaccine is not related to this death given long length of time in between date of vaccine and date of death. Pt's problem list in medical chart below: Active Problems- 16 Active Problems PROBLEM LAST MOD PROVIDER Pain in lower limb (SCT 10601006) (ICD-9-CM 09/08/2015 729.5) Amnesia (SCT 48167000) (ICD-9-CM 780.93) 11/24/2014 (ICD-9-CM 309.0); Adjustment Disorder with 06/04/2013 depressed mood (ICD-9-CM 309.0) (ICD-9-CM 401.9); Benign hypertension 11/20/2012 (ICD-9-CM 414.9); Coronary Artery Disease * 11/20/2012 (ICD-9-CM 414.9) (ICD-9-CM 695.3); Rosacea * (ICD-9-CM 695.3) 03/20/2012 (ICD-9-CM 728.6); Dupuytren's Contracture * 07/13/2010 (ICD-9-CM 728.6) (ICD-9-CM 272.4); Hyperlipidemia * (ICD-9-CM 06/22/2010 272.4) (ICD-9-CM 458.0); Orthostatic Hypotension * 11/12/2009 (ICD-9-CM 458.0) (ICD-9-CM 733.0); Osteoporosis * (ICD-9-CM 09/11/2009 733.0) (ICD-9-CM 579.0); Celiac Disease * (ICD-9-CM 12/19/2005 579.0/579.1) (ICD-9-CM 530.81); Gastroesophageal Reflux 10/26/2005 Disorder * (ICD-9-CM 530.81) (ICD-9-CM 724.2) (ICD-9-CM 280.9); Iron Deficiency Anemia 10/22/2003 (ICD-9-CM 280.9) (ICD-9-CM 600.0); Benign prostatic hyperplasia 01/11/2003 (ICD-9-CM 477.9); Allergic rhinitis * (ICD-9-CM 01/11/2003 477.9)
Headache, Myalgia, Arthralgia, Fever & UrticariaPruritus Narrative: Headache, myalgia, arthralgia, fever 101.1, urticaria/welt to injection site; treated with tylenol; reportedly resolving.
Some of the vaccine leaked out of the arm; Some of the vaccine leaked out of the arm; Patient is due for his second dose of the Pfizer vaccine but patient was sick; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ADMINISTRATION SITE EXTRAVASATION (non-serious), UNDERDOSE (non-serious), outcome "unknown" and all described as "Some of the vaccine leaked out of the arm"; ILLNESS (non-serious), outcome "unknown", described as "Patient is due for his second dose of the Pfizer vaccine but patient was sick".  Additional information: Patient was injected into the muscle with the Pfizer Covid vaccine, and it was noticed that some of the vaccine leaked out of the arm. Patient is due for his second dose of the Pfizer vaccine but patient was sick.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I noticed what I thought were little bites on the back of right my calf and right thigh since I had been camping. The little bites turned into a rash. I took photos of it and sent it to my doctor. I was treating it with calamine lotion since it was itchy. On 04/30/2022 my doctor gave me a prescription of triamcinolone acetonide ointment USP 1%. I was putting it on the rash twice daily. It did not help and the rash got worse. On 05/01/2022 the rash had spread on the back of my calf to the back of my knee and half way up my thigh. I also experience swollen legs and ankles. On 05/02/2022 I went to urgent care and was told it was not poison oak, but it was Shingles. He prescribed valacyclovir which I take three times a day for 7 days. The rash is painful and itchy, but it seems to have stop progressing and it is drying out. I am still not able to walk because my leg is so swollen and painful. I keep it elevated and I am icing it every hour to an hour and a half.
Information has been received from a physician assistant concerning a female patient of unknown age. The patient's medical history, concurrent condition and concomitant therapy were not provided. On unknown dates, the patient was vaccinated with 3 doses of VARIVAX (Merck) (lot numbers, expiration dates, dose and route unspecified) at another unspecified office. On an unspecified date after receiving the second of VARIVAX (Merck), the patient developed chickenpox. The patient's mother called to report this happened. However, the reporter had not seen the patient in the office yet so the chickenpox diagnosis hadn't been confirmed by reporter's office. The outcome of chickenpox was unknown. The causality was not provided. Additional information has been requested.
On August 23 I tested positive for COVID-19 because I was having a runny nose and I had a cough with a temp of 99. Called the doctor that prescribed Paxlovid, I took it for five days and had a nasty taste in my mouth. I then tested myself again I think on September 8th or 9th. I had a doctors appoint but because I had COVID-19 prior I was required to go get tested before I could see my doctor in office. I went to one of the required locations and tested negative. I was then able to go to my doctor and he did find my hemoglobin was .2 lower than it was before. I am not sure if this has anything to do with COVID-19. Isolated for 14 days
FEVER, BODY ACHES, NAUSEA, LOW APPETITE, WEAKNESS (FLU-LIKE SYMPTOMS) FOR 24 HOURS
(name) had a seizure within 5 minutes or less of the first dose.; This is a spontaneous report from a contactable consumer or other non-HCP. A 16-years-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER8729) via an unspecified route of administration in Right Arm on 09Apr2021 00:30 as single dose for covid-19 immunization. Medical history included depression and seizure. The patient's concomitant medications were not reported. On 09Apr2021 00:30, the patient had a seizure within 5 minutes or less of the first dose. Therapeutic measures were taken as a result of had a seizure within 5 minutes or less of the first dose. The outcome of event was recovering.
Began with a rash on the left side of her body the day after the vaccine was given. Developed blisters, diagnosed w/ shingles.
Woke up with lower back pain, thought it would go away in a couple of days but still have it  Period came 5 days early, the morning after the vaccine (trying to conceive so am monitoring).. has had a heavier flow than normal. I also am on day 6 and it hasn?t gotten lighter with still bright red blood which doesn?t usually happen
This spontaneous report was received from a healthcare worker (also reported as nurse) refers to a patient of unknown age and gender. Concurrent conditions, medical history and allergies were not reported. On 22-DEC-2014, the patient was vaccinated with a dose of GARDASIL, (strength, dose, route and anatomical location were not reported), (lot # K009482, expiration date: 06-MAR-2017), which was incorrect stored since 02-DEC-2014. No adverse effects were reported and no product quality complaint (PQC) was filed. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a physician concerning a female who was vaccinated with a dose of Gardasil.  Subsequently the patient experienced "bone pain" around the injection site.  Unspecified medical attention was sought.  The patient's "bone pain" around the injection site persisted.  Additional information has been requested.
Mom noted redness swelling and induration to her right thigh that she believed to be from a bug bite. Pt was seen in the office on 4/21/16.
Flushing on face reported by pt after 10 mins from vaccination. No SOB or other sx noted. Pt waited in office for 50 mins after and Dr. examined her. Advised to take benadryl and go to ER if sx persisted or worsened.
Narrative:  At appointment for second shingrix dose, patient stated that he experienced arm and feet/ankle pains and swelling that took three days for the swelling to come down and a month to get back to his walking routine.
Nausea, vomiting, muscle aches, soreness, redness at injection site, swelling at injection site, headache, weakness, joint pain, sweats, chills, fever
Persistent headache and sinus pressure beginning 3 days after vaccine. Headache has lasted for 6 plus days
Headache; Fatigue; Muscle fatigue; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 vaccine; solution for injection; lot number: EN6203), via an unspecified route of administration on 11Mar2021 09:30 (at the age of 44 -years-old) as unknown, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. On 13Mar2021, the patient experienced headache, fatigue, and muscle fatigue. No treatment was received for the events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
mom states noticed knot on child's lt leg p/vax 3/1/99;states knot got worse until this week it was size of an egg w/pus on the top;mom stated it broke open;took child to MD & has been referred to another MD for removal of sterile abscess
Meniere's disease; patient received the first dose 8 weeks ago; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program.  A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 19Mar2021 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced Meniere's disease on an unspecified date. It was also reported on 10May2021 that the patient received the first dose 8 weeks ago (as reported) on 19Mar2021. The patient asked her doctors if she can get the second dose,  and they agreed but her other doctor disagreed. The patient was asking if she can get the second dose even if it's been 8 weeks from the first dose. The clinical outcome of Meniere's disease and patient received the first dose 8 weeks ago was unknown.  The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. On approximately 16-OCT-2014 (reported as "either on 15-OCT-2014 or 16-OCT-2014) the patient was vaccinated with ZOSTAVAX, (single dose (unspecified) route of administration: intramuscular). In approximately October 2014 the patient experienced pain in the shoulder and whole arm in which the ZOSTAVAX was administered. ZOSTAVAX might have been administered intramuscularly. The outcome of pain in the shoulder was reported as not recovered/not resolved. Patient sought medical attention (came to pharmacy). No lab diagnostic studies were performed. No treatment was given for adverse event. Additional information has been requested.
pt recvd vax & exp an area of pigment discoloration @ inject site; recvd 2nd Tetramune @ 4mos of age in the opposite leg; again, exp discoloration; @ time of report 19MAY94, discoloration still present in both legs;
Initial information received on 17-Oct-2018 regarding an unsolicited valid non-serious case received from a consumer. This case involves a four patients who had reactions, while he/she received vaccine FLUZONE QUADRIVALENT. The patients past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site. The patient experienced a non-serious reactions (adverse event) (Unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Other relevant tests included no lab data. Final diagnosis was had reactions. It was not reported if the patient received a corrective treatment. The patient outcome was not reported. List of documents held by sender: none.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with improperly stored VARIVAX (lot # L034368 with expiration date of 08-SEP-2017, dose and route unknown), which was exposed to the following condition: 8.8 Fahrenheit for 1 hour and 9 minutes with no previous temperature excursion, digital data logger was reported as yes. No adverse symptoms were reported. This is one of two reports from the same reporter. Additional information has been requested.
Collapsed; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (Unknown). The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in 2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for COVID-19 immunization. The following information was reported: LOSS OF CONSCIOUSNESS (hospitalization) with onset 2022, outcome "unknown", described as "Collapsed". The patient was hospitalized for loss of consciousness (hospitalization duration: 8 day(s)). Clinical course included the patient administered Pfizer booster vaccine and collapsed in their house for three days and been hospitalized for 8 days, wanted to know the adverse reaction information since the doctors have no clue to what happened   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
very high fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (very high fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Fever.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PYREXIA (very high fever). At the time of the report, PYREXIA (very high fever) outcome was unknown.
Pt. had received her first Moderna Covid vaccine on 4/10/21 - lot # 037A21B through the district health department. Pt. reports that her husband was instructed from a hospital that they should receive their 2nd vaccine 14 days later. Pt. then attended the vaccination clinic on 4/28/2021 and received her 2nd vaccine. The time frame between the two vaccines was 18 days. Pt. was contacted on 5/6/2021 and reports that she had minimal side effects for the 2nd vaccine which included body aches, and fatigue.
Intussusception, emesis went to hospital ER on 4/28/2010. Treatment: IV hydration, ZOFRAN, PEPCID.
This case was reported by a consumer and described the occurrence of flu like symptoms in a 54-year-old female subject who was vaccinated with influenza virus vaccine (Fluarix, GlaxoSmithKline) for prophylaxis. A physician or other health care professional has not verified this report. On 6 November 2007 at 15:30 the subject received unspecified dose of Fluarix (unknown, right arm). On 7 November 2007, 1 day after vaccination with Fluarix, the subject experienced flu like symptoms, chills, congestion (nos), fever, sore throat, pain and headache. The patient required medical attention at her physician's office. At the time of reporting the events were improved.
A physician reported that his 20 year old daughter received Flu Shield on 11/5/99 and subsequently developed an acute central nervous system demyelinating disorder manifested by marked tremors of her extremities and body, as well as prominent cerebellar signs including marked gait disturbance. She was hospitalized
5/16 Red swollen at injection site and tingling lips, pain and warmth at injection site.